Skip to main content

Table 1 Basic demographic and clinical characteristics of the participants

From: Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial

 

Tranexamic Group (n = 115)

Misoprostol Group (n = 115)

Control Group (n = 115)

P-value

Maternal age (years)

29.59 ± 4.15

28.70 ± 4.51

29.90 ± 5.15

0.125

BMI (kg/m2)

30.56 ± 3.60

30.54 ± 4.30

30.19 ± 3.44

0.903

Parity

- Primigravida

- Para 1

- Para 2 or more

7 (6.09%)

13 (11.30%)

95 (82.61%)

8 (6.96%)

9 (7.83%)

98 (85.22%)

7 (6.09%)

18 (15.65%)

90 (78.26%)

0.480

GA at delivery

38.46 ± 0.97

38.50 ± 0.96

38.38 ± 0.95

0.622

CS Indication

- previous CS

- CPD

- Abnormal presentation

- Placenta Previa

- ICSI

86 (74.8%)

3 (2.6%)

11 (9.6%)

12 (10.4%)

3 (2.6%)

86 (74.8%)

5 (4.3%)

9 (7.8%)

11 (9.6%)

4 (3.5%)

76 (66.1%)

8 (7.0%)

15 (10.4%)

14 (12.2%)

2 (1.7%)

0.667

Pre-operative Hb (gm/dl)

11.17 ± 0.89

11.42 ± 1.05

11.21 ± 1.11

0.146

Pre-operative HCT (%)

34.20 ± 2.64

34.94 ± 3.42

34.70 ± 3.24

0.188

Estimated blood volume (ml)

7169 ± 546

7121 ± 719

7108 ± 556

0.726

CS Duration (minutes)

73.88 ± 14.95

77.19 ± 11.12

74.24 ± 15.26

0.142

Interval from skin incision to complete fetal and placental extraction (minutes)

15.15 ± 1.14

15.10 ± 0.89

14.95 ± 1.38

0.385